Gremese, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 10.614
AS - Asia 7.995
EU - Europa 7.379
SA - Sud America 1.634
AF - Africa 323
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 23
AN - Antartide 2
Totale 28.006
Nazione #
US - Stati Uniti d'America 10.248
SG - Singapore 3.694
CN - Cina 1.785
IT - Italia 1.460
BR - Brasile 1.332
DE - Germania 1.233
SE - Svezia 1.132
FR - Francia 888
VN - Vietnam 735
PL - Polonia 560
IE - Irlanda 415
UA - Ucraina 387
GB - Regno Unito 385
IN - India 341
ID - Indonesia 269
FI - Finlandia 253
HK - Hong Kong 229
CA - Canada 194
RU - Federazione Russa 190
JP - Giappone 183
AR - Argentina 120
TR - Turchia 117
BD - Bangladesh 115
MX - Messico 104
IQ - Iraq 89
ZA - Sudafrica 83
NL - Olanda 81
BE - Belgio 77
ES - Italia 57
AT - Austria 56
KR - Corea 56
SA - Arabia Saudita 55
CI - Costa d'Avorio 52
PK - Pakistan 52
IR - Iran 45
VE - Venezuela 43
EC - Ecuador 42
MA - Marocco 40
CZ - Repubblica Ceca 35
AU - Australia 32
CH - Svizzera 31
PH - Filippine 29
TN - Tunisia 29
CO - Colombia 28
LT - Lituania 26
EG - Egitto 24
KE - Kenya 21
UZ - Uzbekistan 21
AE - Emirati Arabi Uniti 20
JO - Giordania 20
CL - Cile 19
IL - Israele 18
MY - Malesia 17
DZ - Algeria 16
NP - Nepal 15
PE - Perù 15
PY - Paraguay 14
RO - Romania 14
AZ - Azerbaigian 12
EU - Europa 12
CR - Costa Rica 11
GR - Grecia 11
HN - Honduras 11
UY - Uruguay 11
BO - Bolivia 10
ET - Etiopia 10
NG - Nigeria 9
PT - Portogallo 9
TW - Taiwan 9
EE - Estonia 8
JM - Giamaica 8
PA - Panama 8
TT - Trinidad e Tobago 8
A2 - ???statistics.table.value.countryCode.A2??? 7
AL - Albania 7
DK - Danimarca 7
GE - Georgia 7
LV - Lettonia 7
RS - Serbia 7
SN - Senegal 7
AO - Angola 6
BG - Bulgaria 6
KG - Kirghizistan 6
LA - Repubblica Popolare Democratica del Laos 6
MD - Moldavia 6
TH - Thailandia 6
GT - Guatemala 5
HU - Ungheria 5
KH - Cambogia 5
LB - Libano 5
LK - Sri Lanka 5
NO - Norvegia 5
AM - Armenia 4
DO - Repubblica Dominicana 4
GA - Gabon 4
LU - Lussemburgo 4
MM - Myanmar 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
BH - Bahrain 3
Totale 27.934
Città #
Singapore 1.960
Chandler 1.270
Ashburn 1.114
San Jose 966
Warsaw 504
Dublin 390
Beijing 358
New York 320
Rome 280
Los Angeles 254
Ho Chi Minh City 248
Fairfield 244
Jakarta 242
Wilmington 235
Ann Arbor 234
Dearborn 225
Jacksonville 216
Lauterbourg 204
San Mateo 204
Hong Kong 200
Milan 199
The Dalles 197
Woodbridge 193
Hanoi 190
Houston 182
Dallas 180
Nanjing 165
Munich 161
Seattle 157
Boston 156
Hefei 154
Tokyo 153
Chicago 145
Frankfurt am Main 136
Cattolica 126
São Paulo 123
Princeton 112
Moscow 98
Helsinki 97
Bremen 96
Cambridge 84
Marseille 83
Lawrence 77
London 72
Brussels 67
Santa Clara 66
Redwood City 63
St Louis 58
Buffalo 57
Nuremberg 56
Pune 55
Orem 54
Abidjan 52
Boardman 52
Montreal 51
North Bergen 51
Seoul 49
Izmir 48
Council Bluffs 46
Nanchang 46
Paris 45
Rio de Janeiro 42
Norwalk 41
Chennai 40
Shanghai 40
Turku 40
Denver 39
Hangzhou 39
Toronto 38
Tianjin 36
Atlanta 35
Johannesburg 35
Da Nang 34
Kent 34
Phoenix 34
Kunming 33
Redmond 33
Baghdad 32
Guangzhou 32
Haiphong 32
Lappeenranta 32
Amsterdam 31
Brooklyn 31
Hebei 31
Mexico City 30
Lancaster 29
Washington 28
Falls Church 27
Shenyang 27
Stockholm 27
Mountain View 26
Curitiba 25
Dhaka 25
Manchester 25
Naples 25
San Francisco 25
Vienna 25
Brasília 24
Brno 23
Düsseldorf 23
Totale 15.148
Nome #
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 527
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue 438
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 356
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 344
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 341
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 304
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 264
COVID-19 atypical Parsonage-Turner syndrome: a case report 260
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 258
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 244
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 232
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 231
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 229
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 224
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 210
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 208
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 203
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue. 198
Residual respiratory impairment after COVID-19 pneumonia 191
Malnutrition in COVID-19 survivors: prevalence and risk factors 191
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 191
An autosomal recessive DNASE1L3-related autoimmune disease with unusual clinical presentation mimicking systemic lupus erythematosus 189
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 187
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 185
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 183
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections 180
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 180
Malnutrition in COVID-19 survivors: prevalence and risk factors 179
Adult onset Still's disease and pregnancy 177
The role of High-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on Vascular endothelial growth factor. 175
COVID-19 atypical Parsonage-Turner syndrome: a case report 174
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 172
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 172
Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis 171
Residual respiratory impairment after COVID-19 pneumonia 169
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 166
Detection of bone erosions in early rheumatoid arthritis: 3D ultrasonography versus computed tomography 166
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 164
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 163
Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels 163
Effects of l-Arginine Plus Vitamin C Supplementation on Physical Performance, Endothelial Function, and Persistent Fatigue in Adults with Long COVID: A Single-Blind Randomized Controlled Trial 162
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 162
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 161
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 161
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 160
Baseline shoulder ultrasonography is not a predictive marker of response to glucocorticoids in patients with polymyalgia rheumatica: A 12-month followup study 158
Selective Inhibitors of T Cell Receptor Recognition of Antigen–MHC Complexes for Rheumatoid Arthritis 157
Sarilumab use in severe SARS-CoV-2 pneumonia 156
Has shoulder ultrasonography got a predictive value in Polymialgia Rheumatica. In: EULAR. 155
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 154
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 153
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 147
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy 144
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 144
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 143
Effects of l-Arginine Plus Vitamin C Supplementation on l-Arginine Metabolism in Adults with Long COVID: Secondary Analysis of a Randomized Clinical Trial 140
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 140
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases) 140
Extension of Lung Damage at Chest Computed Tomography in Severely Ill COVID-19 Patients Treated with Interleukin-6 Receptor Blockers Correlates with Inflammatory Cytokines Production and Prognosis 139
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 138
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis 135
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 135
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 131
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 131
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 130
Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs): tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestations 128
Comparative analysis of synovial inflammation after SARS-CoV-2 infection 128
The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk 127
Is Citrullination Required for the Presence of Restricted Clonotypes Reacting With Type II Collagen? Comment on the Article by Chemin et al 127
Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status 127
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 127
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 127
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 126
Immune-Guided Therapy of COVID-19 126
Simultaneous onset of mycobacterium kansasii pulmonary infection and systemic lupus erythematosus: A case report 125
Use of First-Line Oral Analgesics during and after COVID-19: Results from a Survey on a Sample of Italian 696 COVID-19 Survivors with Post-Acute Symptoms 123
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19 122
IL COINVOLGIMENTO ARTICOLARE NEL LES: LA FORMA CLASSICA E LA VARIANTE “RHUPUS” 122
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered 122
Intensive training programme for ultrasound-guided minimally invasive synovial tissue biopsy on knees and wrists in different phases of inflammation 121
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 121
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. 121
Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis 120
Synovial predictors of differentiation to definite arthritis in patients with seronegative undifferentiated peripheral inflammatory arthritis: MicroRNA signature, histological, and ultrasound features 120
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 120
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response. 119
Adult Onset Still's Disease and Radiotherapy treatment for breast cancer: Case report about management of this rare association and literature review 119
An unusual lung involvement in scleroderma: lipoid pneumonia 119
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 118
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 117
Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig 116
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus 115
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 115
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 114
Five-year survival on infliximab in rheumatoid arthritis patients: analysis from an Italian registry (GISEA) by different calendar years 114
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 114
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 113
Depression and Endothelial Dysfunction in Psoriatic Arthritis: Is There Any Possible Relationship? 113
Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients 112
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 112
Totale 16.845
Categoria #
all - tutte 123.305
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.305


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021229 0 0 0 0 0 0 0 0 0 0 187 42
2021/20221.771 198 110 56 104 110 54 40 224 88 127 258 402
2022/20234.037 455 473 356 669 326 510 195 286 448 106 131 82
2023/20242.242 86 549 83 104 92 350 193 90 40 119 295 241
2024/20254.393 104 101 352 175 357 176 184 187 679 451 849 778
2025/202610.536 1.664 385 729 1.337 1.791 640 1.882 536 653 799 120 0
Totale 28.415